chr3-151338810-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_022788.5(P2RY12):āc.36T>Gā(p.Gly12=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.846 in 1,612,836 control chromosomes in the GnomAD database, including 578,841 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.88 ( 59249 hom., cov: 31)
Exomes š: 0.84 ( 519592 hom. )
Consequence
P2RY12
NM_022788.5 synonymous
NM_022788.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0130
Genes affected
P2RY12 (HGNC:18124): (purinergic receptor P2Y12) The product of this gene belongs to the family of G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor is involved in platelet aggregation, and is a potential target for the treatment of thromboembolisms and other clotting disorders. Mutations in this gene are implicated in bleeding disorder, platelet type 8 (BDPLT8). Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jul 2013]
MED12L (HGNC:16050): (mediator complex subunit 12L) The protein encoded by this gene is part of the Mediator complex, which is involved in transcriptional coactivation of nearly all RNA polymerase II-dependent genes. The Mediator complex links gene-specific transcriptional activators with the basal transcription machinery. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 3-151338810-A-C is Benign according to our data. Variant chr3-151338810-A-C is described in ClinVar as [Benign]. Clinvar id is 261633.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-151338810-A-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.013 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.959 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
P2RY12 | NM_022788.5 | c.36T>G | p.Gly12= | synonymous_variant | 3/3 | ENST00000302632.4 | NP_073625.1 | |
MED12L | NM_001393769.1 | c.2251-11249A>C | intron_variant | ENST00000687756.1 | NP_001380698.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
P2RY12 | ENST00000302632.4 | c.36T>G | p.Gly12= | synonymous_variant | 3/3 | 1 | NM_022788.5 | ENSP00000307259 | P1 | |
MED12L | ENST00000687756.1 | c.2251-11249A>C | intron_variant | NM_001393769.1 | ENSP00000508695 | A2 |
Frequencies
GnomAD3 genomes AF: 0.881 AC: 133847AN: 151958Hom.: 59200 Cov.: 31
GnomAD3 genomes
AF:
AC:
133847
AN:
151958
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.868 AC: 217850AN: 250966Hom.: 94810 AF XY: 0.867 AC XY: 117607AN XY: 135636
GnomAD3 exomes
AF:
AC:
217850
AN:
250966
Hom.:
AF XY:
AC XY:
117607
AN XY:
135636
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.842 AC: 1230617AN: 1460760Hom.: 519592 Cov.: 61 AF XY: 0.845 AC XY: 613838AN XY: 726732
GnomAD4 exome
AF:
AC:
1230617
AN:
1460760
Hom.:
Cov.:
61
AF XY:
AC XY:
613838
AN XY:
726732
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.881 AC: 133956AN: 152076Hom.: 59249 Cov.: 31 AF XY: 0.882 AC XY: 65583AN XY: 74340
GnomAD4 genome
AF:
AC:
133956
AN:
152076
Hom.:
Cov.:
31
AF XY:
AC XY:
65583
AN XY:
74340
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3013
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 09, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Platelet-type bleeding disorder 8 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at